Nicole LaBrosse
SVP, Chief Financial Officer at Halozyme Therapeutics · 16 reported transactions in 1 company · latest report Feb 23, 2026
Their trades
Shares withheld for tax | Feb 23, 2026 | |||
Exercised options | Feb 23, 2026 | |||
Shares withheld for tax | Feb 20, 2026 | |||
Exercised options | Feb 20, 2026 | |||
Shares withheld for tax | Feb 16, 2026 | |||
Exercised options | Feb 16, 2026 | |||
Shares withheld for tax | Feb 16, 2026 | |||
Exercised options | Feb 16, 2026 | |||
Shares withheld for tax | Feb 16, 2026 | |||
Exercised options | Feb 16, 2026 |